Contraception for Women with Premature Heart Disease and MI History

Absolutely Contraindicated Methods

The American College of Cardiology and American Heart Association explicitly state that estrogen-containing contraceptives are potentially harmful for women with coronary artery disease who are at high risk of thromboembolic events, with combined oral contraceptives increasing MI risk with a relative risk of 1.7 (1.5-1.9) and ischemic stroke risk with RR 1.7 (1.5-1.9) even in healthy women 2, 3, 4, 1

The American College of Cardiology recommends the levonorgestrel-releasing intrauterine device (LNG-IUD) as a preferred method for women at high risk of thromboembolism, providing highly effective contraception (pregnancy rates <1% per year) with minimal systemic hormone exposure, avoiding thrombotic risks associated with estrogen, and offering additional non-contraceptive benefits including reduced menstrual blood loss by 40-50% 1, 5, 6

The European Society of Cardiology notes that the copper IUD is an equally safe and highly effective alternative for patients preferring hormone-free contraception, with no systemic hormonal effects and no thrombotic risk, but should be avoided only if patient has hematocrit >55% due to increased menstrual bleeding risk 1, 6
The American College of Cardiology suggests that subdermal progestin implants are highly effective with failure rates <1% per year and are appropriate for women with coronary artery disease as they avoid estrogen exposure 1

The American College of Cardiology advises that progestin-only pills (POPs) may be considered but are less ideal due to higher failure rates and need for strict daily adherence, with a meta-analysis showing no significant increase in MI risk (OR 1.07, 95% CI 0.62-1.84), but requiring taking pills at exact same time daily, making them less forgiving than long-acting methods 2, 3, 1
The European Society of Cardiology guidelines specifically note that depot medroxyprogesterone acetate (DMPA) should be avoided or used with significant caution due to fluid retention concerns, which may be problematic in patients with cardiovascular disease 1, 4, 6

The American College of Cardiology recommends that if permanent contraception is desired, tubal ligation or hysteroscopic sterilization (Essure device) may be considered, though surgical and anesthesia risks must be carefully weighed, and vasectomy of male partner is often the safest permanent option when female partner has significant cardiovascular disease 4, 1

The American College of Cardiology emphasizes that unplanned pregnancy poses serious risks due to teratogenic effects of cardiovascular medications (ACE inhibitors, ARBs, warfarin), and contraceptive counseling should occur immediately and be revisited regularly, including discussion of failure rates of each method, specific risks of pregnancy with her cardiac condition, and patient values and preferences 4, 7, 1

The European Heart Journal recommends that blood pressure should be checked at baseline and if any hormonal method is used, and for LNG-IUD insertion, consider hospital setting given cardiac history to monitor for vasovagal reactions (occur in 5% of insertions) 5, 6